CCEL Valuation

Cryo-Cell International Inc

Add to Watchlist

Advanced Chart

5.002

+0.182(3.776%)1D

Overview
Forecast
Valuation
Earnings

CCEL Relative Valuation

CCEL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CCEL is overvalued; if below, it's undervalued.

Historical Valuation

Cryo-Cell International Inc (CCEL) is now in the Fair zone, suggesting that its current forward PS ratio of 1.34 is considered Fairly compared with the five-year average of 22.86. The fair price of Cryo-Cell International Inc (CCEL) is between 1.64 to 6.90 according to relative valuation methord.

Relative Value

Fair Zone

1.64-6.90

Current Price：5.07

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

-2.57

P/B

Median3y

-233.05

Median5y

-143.47

13.93

FCF Yield

Median3y

0.32

Median5y

3.97

Competitors Valuation Multiple

The average P/S ratio for CCEL's competitors is 0.56, providing a benchmark for relative valuation. Cryo-Cell International Inc Corp (CCEL) exhibits a P/S ratio of 1.34, which is 140.62% above the industry average. Given its robust revenue growth of 1.49%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

CCEL.A

Cryo-Cell International Inc

1.34

Average P/S: 0.56

1.49%